Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lakhani

Showing results (251-260 of 311) with videos related to

Pageof 32
Sort By:
Human Molecular Genetics|July 6, 2016
Long-range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancerMichael J G Milevskiy, Fares Al-Ejeh, Jodi M Saunus, et al.
The American Journal of Surgical Pathology|June 14, 2013
Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistryDavid J Dabbs, Stuart J Schnitt, Felipe C Geyer, et al.
Ebiomedicine|March 9, 2026
Integrating breast tumour homologous recombination deficiency status to aid germline BRCA1 and BRCA2 variant classificationCristina Fortuno, Jia Zhang, Lambros T Koufariotis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2020
Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline UpdateKimberly H Allison, M Elizabeth H Hammond, Mitchell Dowsett, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 25, 2017
Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancerJia-Min B Pang, Peter Savas, Andrew P Fellowes, et al.
NPJ Breast Cancer|July 3, 2019
LobSig is a multigene predictor of outcome in invasive lobular carcinomaAmy E McCart Reed, Samir Lal, Jamie R Kutasovic, et al.
Breast Cancer Research and Treatment|December 5, 2009
Subtypes of familial breast tumours revealed by expression and copy number profilingNic Waddell, Jeremy Arnold, Sibylle Cocciardi, et al.
Cancers|September 28, 2021
Elevating CDCA3 Levels Enhances Tyrosine Kinase Inhibitor Sensitivity in TKI-Resistant EGFR Mutant Non-Small-Cell Lung CancerKatherine B Sahin, Esha T Shah, Genevieve P Ferguson, et al.
Archives of Pathology & Laboratory Medicine|January 14, 2020
Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline UpdateKimberly H Allison, M Elizabeth H Hammond, Mitchell Dowsett, et al.
Nature Communications|March 28, 2015
ID4 controls mammary stem cells and marks breast cancers with a stem cell-like phenotypeSimon Junankar, Laura A Baker, Daniel L Roden, et al.
Pageof 32

Showing results (251-260 of 311) with videos related to

Sort By:
Pageof 32
Human Molecular Genetics|July 6, 2016
Long-range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancerMichael J G Milevskiy, Fares Al-Ejeh, Jodi M Saunus, et al.
The American Journal of Surgical Pathology|June 14, 2013
Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistryDavid J Dabbs, Stuart J Schnitt, Felipe C Geyer, et al.
Ebiomedicine|March 9, 2026
Integrating breast tumour homologous recombination deficiency status to aid germline BRCA1 and BRCA2 variant classificationCristina Fortuno, Jia Zhang, Lambros T Koufariotis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2020
Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline UpdateKimberly H Allison, M Elizabeth H Hammond, Mitchell Dowsett, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 25, 2017
Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancerJia-Min B Pang, Peter Savas, Andrew P Fellowes, et al.
NPJ Breast Cancer|July 3, 2019
LobSig is a multigene predictor of outcome in invasive lobular carcinomaAmy E McCart Reed, Samir Lal, Jamie R Kutasovic, et al.
Breast Cancer Research and Treatment|December 5, 2009
Subtypes of familial breast tumours revealed by expression and copy number profilingNic Waddell, Jeremy Arnold, Sibylle Cocciardi, et al.
Cancers|September 28, 2021
Elevating CDCA3 Levels Enhances Tyrosine Kinase Inhibitor Sensitivity in TKI-Resistant EGFR Mutant Non-Small-Cell Lung CancerKatherine B Sahin, Esha T Shah, Genevieve P Ferguson, et al.
Archives of Pathology & Laboratory Medicine|January 14, 2020
Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline UpdateKimberly H Allison, M Elizabeth H Hammond, Mitchell Dowsett, et al.
Nature Communications|March 28, 2015
ID4 controls mammary stem cells and marks breast cancers with a stem cell-like phenotypeSimon Junankar, Laura A Baker, Daniel L Roden, et al.
Pageof 32